Spots Global Cancer Trial Database for A Clinical Trial of ICP-192 in Treated Patients With Advanced Solid Tumors With FGF/FGFR Gene Alterations
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Clinical Trial of ICP-192 in Treated Patients With Advanced Solid Tumors With FGF/FGFR Gene Alterations
Official Title: A Phase II Clinical Trial to Evaluate the Efficacy and Safety of ICP-192 in Treated Patients With Advanced Solid Tumors With FGF/FGFR Gene Alterations
Study ID: NCT05372120
Conditions
Interventions
Study Description
Brief Summary: This is a phase II clinical trial in treated patients with advanced solid tumors with FGF/FGFR gene alterations. The purpose of this study is to evaluate the efficacy and safety of ICP-192.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The first affiliated hospital of bengbu medical college, Bengbu, Anhui, China
Anhui Provincal Cancer Hospital, Hefei, Anhui, China
Cancer Hospital.Chinese Academy of Medical Sciences, Beijing, Beijing, China
Beijing Cancer Hospital, Beijing, Beijing, China
Fujian Cancer Hospital, Fuzhou, Fujian, China
The First Affiliated Hospital of Lanzhou University, Lanzhou, Gansu, China
Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, Guangdong, China
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Harbin Medical University cancer hospital, Harbin, Heilongjiang, China
Henan Provincial People's Hospital, Zhengzhou, Henan, China
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Henan Tumor Hospital, Zhengzhou, Henan, China
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Union Hospital Toji Medical College Huazhong University of Science and Technology, WuHan, Hubei, China
Tongji Hospital Tongji Medical College of HUST, Wuhan, Hubei, China
Xiangya Hospital Central South University, Changsha, Hunan, China
Hunan Cancer Hospital, Changsha, Hunan, China
Hunan Tumor Hospital, Changsha, Hunan, China
Nantong Cancer Hospital, Nantong, Jiangsu, China
Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China
The first hospital of jilin University, Changchun, Jilin, China
Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China
Shandong Provincial Institute of Cancer Prevention and Treatment, Jinan, Shandong, China
QiLu Hospital of Shandong University, Jinan, Shandong, China
Linyi Cancer Hospital, Linyi, Shandong, China
Shanghai Ninth People's Hospital, Shanghai JiaoTong University School Medicine, Shanghai, Shanghai, China
Zhongshan Hospital Affiliated to Fudan University, Shanghai, Shanghai, China
Shanghai East Hospital, Shanghai, Shanghai, China
The First Affiliated Hospital of Xi An Jiaotong University, Xi'an, Shanxi, China
Sichuan Tumor Hospital, Chengdu, Sichuan, China
West China Hospital, Sichuan University, Chengdu, Sichuan, China
Second People's Hospital of Yibin City, Yibin, Sichuan, China
Tianjin medical university cancer institute&hospital, Tianjin, Tianjin, China
Shaoyifu Hospital of Zhejiang University Medical College, Hangzhou, Zhejiang, China
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
Contact Details
Name: Ye Guo
Affiliation: Shanghai East Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
